obsolete 发表于 2025-3-23 13:25:40

https://doi.org/10.1007/978-3-642-01144-3Antigen; Cancer therapy; Chloroplast; Expression; Hybridoma; Immunoglobulins; Immunology; Polymerasekettenr

分期付款 发表于 2025-3-23 16:27:01

978-3-662-49594-0Springer-Verlag GmbH Germany, part of Springer Nature 2010

MURAL 发表于 2025-3-23 18:11:57

Antibody Engineering Volume 1978-3-642-01144-3Series ISSN 1949-2448 Series E-ISSN 1949-2456

Efflorescent 发表于 2025-3-23 22:14:45

http://reply.papertrans.cn/16/1585/158469/158469_14.png

TIA742 发表于 2025-3-24 05:42:46

1949-2448number of protocols.With both new and well established techAntibodies are indispensable tools for research, diagnosis, and therapy. Recombinant approaches allow the modification and improvement of nearly all antibody properties, such as affinity, valency, specificity, stability, serum half-life, ef

不能仁慈 发表于 2025-3-24 08:48:48

http://reply.papertrans.cn/16/1585/158469/158469_16.png

BARB 发表于 2025-3-24 14:46:09

第179864主题贴--第2楼 (沙发)

Eosinophils 发表于 2025-3-24 18:34:22

第192842主题贴--第2楼 (沙发)

indenture 发表于 2025-3-24 21:13:48

第192841主题贴--第2楼 (沙发)

justify 发表于 2025-3-25 01:22:13

第179863主题贴--第2楼 (沙发)
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Antibody Engineering Volume 1; Roland Kontermann,Stefan Dübel Book 2010Latest edition Springer-Verlag GmbH Germany, part of Springer Natur